官方服务：
资源简介：
Clinical Study Reports on Orlistat released by EMA
应用场景：
创建时间：
2016-06-09
相关数据集
Supplementary Material for: Use of fluoxetine to reduce weight in adults with overweight or obesity: Abridged republication of the Cochrane Systematic Review
Introduction: Using fluoxetine is one of many weight-loss strategies. A serotonin reuptake inhibitor indicated for depression believed to impact weight control by changing an individual’s appetite; ho
DataCite Commons2022-07-05 更新140
North America Weight Loss Drugs Market
The North America Weight Loss Drugs report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows a
IMR REPORTS50
North America Weight-loss Drugs Market
The North America Weight-loss Drugs market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into competitor dynam
IMR REPORTS30
Umfrage in Deutschland zur Verwendung rezeptfreier Diätmittel zum Abnehmen bis 2023
Im Jahr 2023 gab es zum Zeitpunkt der Befragung in der deutschsprachigen Bevölkerung ab 14 Jahre rund 1,61 Millionen Personen, die in den letzten 3 Monaten rezeptfreie Mittel zum Abnehmen (bzw. zur Un
de.statista.com2024-10-17 更新80
North America Orlistat Capsules Market
The report on North America Orlistat Capsules covers a summarized study of several factors supporting market growth, such as market size, market type, major regions, and end-user applications. The rep
IMR REPORTS50
